Literature DB >> 16377417

Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis.

William Y Song1, Bryan Schaly, Glenn Bauman, Jerry J Battista, Jake Van Dyk.   

Abstract

PURPOSE: To quantify the mitigation of geometric uncertainties achieved with the application of various patient setup techniques during the delivery of hypofractionated prostate cancer treatments, using tumor control probability (TCP) and normal tissue complication probability. METHODS AND MATERIALS: Five prostate cancer patients with approximately 16 treatment CT studies, taken during the course of their radiation therapy (77 total), were analyzed. All patients were planned twice with an 18 MV six-field conformal technique, with 10- and 5-mm margin sizes, with various hypofractionation schedules (5 to 35 fractions). Subsequently, four clinically relevant patient setup techniques (laser guided and image guided) were simulated to deliver such schedules.
RESULTS: As hypothesized, the impact of geometric uncertainties on clinical outcomes increased with more hypofractionated schedules. However, the absolute gain in TCP due to hypofractionation (up to 21.8% increase) was significantly higher compared with the losses due to geometric uncertainties (up to 8.6% decrease).
CONCLUSIONS: The results of this study suggest that, although the impact of geometric uncertainties on the treatment outcomes increases as the number of fractions decrease, the reduction in TCP due to the uncertainties does not significantly offset the expected theoretical gain in TCP by hypofractionation.

Entities:  

Mesh:

Year:  2006        PMID: 16377417     DOI: 10.1016/j.ijrobp.2005.08.037

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

Review 1.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

2.  On voxel-by-voxel accumulated dose for prostate radiation therapy using deformable image registration.

Authors:  Jialu Yu; Nicholas Hardcastle; Kyoungkeun Jeong; Edward T Bender; Mark A Ritter; Wolfgang A Tomé
Journal:  Technol Cancer Res Treat       Date:  2014-11-11

3.  Modality comparison for small animal radiotherapy: a simulation study.

Authors:  Magdalena Bazalova; Geoff Nelson; John M Noll; Edward E Graves
Journal:  Med Phys       Date:  2014-01       Impact factor: 4.071

4.  Interfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression.

Authors:  Cynthia L Eccles; Laura A Dawson; Joanne L Moseley; Kristy K Brock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

Review 5.  Systematic review of hypofractionated radiation therapy for prostate cancer.

Authors:  Nicholas G Zaorsky; Nitin Ohri; Timothy N Showalter; Adam P Dicker; Robert B Den
Journal:  Cancer Treat Rev       Date:  2013-03-01       Impact factor: 12.111

Review 6.  Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.

Authors:  Víctor Macías; Albert Biete
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

7.  Prognostic factors for acute toxicity in prostate cancer patients treated with high-dose hypofractionated radiotherapy.

Authors:  V Macias; R Gonzalez Celador; C Marti-Macia; C Cigarral; L A Perez-Romasanta
Journal:  Clin Transl Oncol       Date:  2013-01-29       Impact factor: 3.405

8.  Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment.

Authors:  Ning Wen; Carri Glide-Hurst; Teamour Nurushev; Lei Xing; Jinkoo Kim; Hualiang Zhong; Dezhi Liu; Manju Liu; Jay Burmeister; Benjamin Movsas; Indrin J Chetty
Journal:  Phys Med Biol       Date:  2012-08-03       Impact factor: 3.609

9.  An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy.

Authors:  Ning Wen; Akila Kumarasiri; Teamour Nurushev; Jay Burmeister; Lei Xing; Dezhi Liu; Carri Glide-Hurst; Jinkoo Kim; Hualiang Zhong; Benjamin Movsas; Indrin J Chetty
Journal:  Phys Med Biol       Date:  2013-10-18       Impact factor: 3.609

10.  Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.

Authors:  Lynsey Devlin; David Dodds; Azmat Sadozye; Philip McLoone; Nicholas MacLeod; Carolynn Lamb; Suzanne Currie; Stefanie Thomson; Aileen Duffton
Journal:  Br J Radiol       Date:  2020-01-30       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.